Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Jazz Pharmaceuticals Receives Approval for Modeyso™ to Treat Recurrent H3 K27M-Mutant Diffuse Midline Glioma

Thursday, August 07, 2025

Jazz Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted accelerated approval for Modeyso dordaviprone

SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics in $412 Million

Wednesday, August 06, 2025

SERB Pharmaceuticals has announced the acquisition of YmAbs Therapeutics The agreement values YmAbs at approximately million in an allcash transaction

Porosome Therapeutics Unveils Breakthrough Discoveries in Alzheimer’s Research

Wednesday, August 06, 2025

Porosome Therapeutics has announced major developments in its neurological treatment platform aimed at tackling the root causes of Alzheimers disease ADThe companys innovative approach offers a potential shift in AD treatment by focusing on disease m...

Axplora Invests €6.5 Million to Expand Vizag Site and Achieves FDA Success Across Indian Operations

Wednesday, August 06, 2025

Axplora has announced a million investment to expand its Vizag site in IndiaThe move aims to increase production capacity and strengthen the companys global supply chain

MetaVia and Syntekabio Partner to Explore New Indications for DA-1241 Using AI Technology

Wednesday, August 06, 2025

MetaVia has announced a research partnership with Syntekabio to explore additional therapeutic uses for DA its investigational oral drug targeting GProteinCoupled Receptor GPR

Bristol Myers Squibb’s Breyanzi Accepted for Priority Review by FDA for Marginal Zone Lymphoma

Tuesday, August 05, 2025

Bristol Myers Squibb has announced that the US Food and Drug Administration FDA has accepted the supplemental biologics licence application sBLA for Breyanzi lisocabtagene maraleucel lisocel

Innovent Receives Approval for IND Application of Oral GLP-1R Agonist IBI3032

Tuesday, August 05, 2025

Innovent Biologics has received approval from the United States Food and Drug Administration FDA for its investigational new drug IND application to begin Phase clinical trials of IBI an oral GLP receptor agonist

WuXi XDC’s DP3 Facility at Wuxi Site Gains GMP Approval, Expands Manufacturing Capacity

Tuesday, August 05, 2025

WuXi XDC has announced the GMP release of its newly launched Drug Product DP facility at the Wuxi site completed at the end of July

Dyne Therapeutics Receives Breakthrough Therapy for DYNE-251 in Duchenne Muscular Dystrophy

Monday, August 04, 2025

Dyne Therapeutics has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation for DYNE a treatment for patients with Duchenne muscular dystrophy DMD who are eligible for exon skipping

Altasciences and VoxCell BioInnovation Collaborate to Enhance Preclinical Drug Development

Friday, August 01, 2025

Altasciences and VoxCell BioInnovation have entered into a strategic collaboration to improve preclinical drug development by combining their respective expertise in drug research and D tissue technology